Skip to main content
Kevin Wolschleger, MD, Cardiology, Grand Rapids, MI

KevinGWolschlegerMD

Cardiology Grand Rapids, MI

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Ambulatory Cardiology Section Chief

Dr. Wolschleger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wolschleger's full profile

Already have an account?

  • Office

    2900 Bradford St Ne
    Grand Rapids, MI 49525
    Phone+1 616-885-5000
    Fax+1 616-885-5020

Education & Training

  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityFellowship, Cardiovascular Disease, 1987 - 1990
  • Corewell Health East Beaumont (Dearborn)
    Corewell Health East Beaumont (Dearborn)Residency, Internal Medicine, 1984 - 1987
  • American University of the Caribbean School of Medicine
    American University of the Caribbean School of MedicineClass of 1984

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1985 - 2025
  • WI State Medical License
    WI State Medical License 1990 - 2007
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Press Mentions

  • Augmented Reality Is the Future of Healthcare Industry
    Augmented Reality Is the Future of Healthcare IndustryDecember 18th, 2019
  • First Patient Enrolls in STEMI DTU Randomized Controlled FDA Trial; Study Aims to Further Demonstrate Impella’s Safety and Effectiveness
    First Patient Enrolls in STEMI DTU Randomized Controlled FDA Trial; Study Aims to Further Demonstrate Impella’s Safety and EffectivenessDecember 16th, 2019
  • Klinische Überprüfung Bestätigt Kosteneffizienz Von Impella Bei Hochrisiko-PCI Und Kardiogenem Schock
    Klinische Überprüfung Bestätigt Kosteneffizienz Von Impella Bei Hochrisiko-PCI Und Kardiogenem SchockNovember 20th, 2019
  • Join now to see all

Professional Memberships